Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
9 Patents
#386 in Paris
#1,854 in France
Theravectys
Forward Citations = 27
17 inventors:
Theravectys
Calculating rank
EPO Patents = 7
Trademarks = 1
Forward Citations = 27
Loading Chart...
Loading Chart...
17 inventors (with patents filed for the assignee):
Pierre Charneau (4 out of 36 patents)
Cecile Bauche (4 out of 7 patents)
Anne-Sophie Beignon (3 out of 4 patents)
4. Emeline Sarry (3 out of 5 patents)
5. Frederic Philippe Coutant (3 out of 5 patents)
6. Karine Courbeyrette (3 out of 3 patents)
7. Sebastian Amigorena (1 out of 12 patents)
8. Franck Perez (1 out of 10 patents)
9. Ana Bejanariu (1 out of 1 patent)
10. Sophie Agaugue (1 out of 1 patent)
11. Lorenzo Tibaldi (1 out of 1 patent)
12. Klervi Even-Desrumaux (1 out of 1 patent)
13. Dmitry Trubetskoy (1 out of 1 patent)
14. Cécile Bauche (1 out of 8 patents)
15. Mohamad Fakruddin Jamiluddin (1 out of 8 patents)
9 patents:
Company Overview
Theravectys is a biotechnology company dedicated to the development of cutting-edge gene therapy solutions for the treatment of infectious diseases, cancers, and genetic disorders. Our innovative vector platform allows for the delivery of therapeutic genes directly into target cells, offering potential cures for a wide range of medical conditions. With a focus on research and development, Theravectys is committed to advancing the field of gene therapy to improve patient outcomes and quality of life.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Theravectys. Retrieved from https://idiyas.com/company/theravectys
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
7 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]